{"title": "Malignant bone marrow disease: New hope for MPN patients", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/stem_cells.xml", "value": "Malignant bone marrow disease: New hope for MPN patients"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/02/190205102523.htm"}], "link": "https://www.sciencedaily.com/releases/2019/02/190205102523.htm", "summary": "Myeloproliferative neoplasms (MPNs) are still difficult to treat. Researchers have discovered a new therapeutic approach that could fundamentally change this situation.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/stem_cells.xml", "value": "Myeloproliferative neoplasms (MPNs) are still difficult to treat. Researchers have discovered a new therapeutic approach that could fundamentally change this situation."}, "published": "Tue, 05 Feb 2019 10:25:23 EST", "published_parsed": [2019, 2, 5, 15, 25, 23, 1, 36, 0], "id": "https://www.sciencedaily.com/releases/2019/02/190205102523.htm", "guidislink": false}